![](/img/cover-not-exists.png)
OP09 Anti TNF-α therapy is a major cost driver in inflammatory bowel disease: Results from the COIN study
M. Van der Valk, M.-J. Mangen, G. Dijkstra, A. van Bodegraven, H. Fidder, D. de Jong, M. Pierik, C.J. van der Woude, M. Romberg-Camps, C. Clemens, J. Jansen, P. van de Meeberg, N. Mahmmod, C. PonsioenVolume:
6
Year:
2012
Language:
english
DOI:
10.1016/s1873-9946(12)60010-5
File:
PDF, 53 KB
english, 2012